D-0500-2026 Class II Ongoing

Recalled by Thea Pharma, Inc. — Waltham, MA

FDA drug recall D-0500-2026 was initiated by Thea Pharma, Inc. on Apr 23, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer. The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
May 6, 2026
Initiation Date
Apr 23, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in France, Distributed by: Thea Pharma Inc., Waltham, MA 02451, NDC 82584-700-11

Reason for recall

Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

Distribution pattern

Nationwide within the United States

Code information

Lot#: 3T36B, Exp. Date October 31, 2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0500-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0500-2026. Report a data issue: hello@regdatalab.com.